University of Wisconsin Milwaukee

UWM Digital Commons
Theses and Dissertations

December 2018

Dickkopf-1 Blocks 17β-estradiol-enhanced Object
Memory Consolidation in Ovariectomized Female
Mice
Lisa Taxier
University of Wisconsin-Milwaukee

Follow this and additional works at: https://dc.uwm.edu/etd
Part of the Other Psychology Commons
Recommended Citation
Taxier, Lisa, "Dickkopf-1 Blocks 17β-estradiol-enhanced Object Memory Consolidation in Ovariectomized Female Mice" (2018).
Theses and Dissertations. 2021.
https://dc.uwm.edu/etd/2021

This Thesis is brought to you for free and open access by UWM Digital Commons. It has been accepted for inclusion in Theses and Dissertations by an
authorized administrator of UWM Digital Commons. For more information, please contact open-access@uwm.edu.

DICKKOPF-1 BLOCKS 17β-ESTRADIOL-ENHANCED OBJECT MEMORY
CONSOLIDATION IN OVARIECTOMIZED FEMALE MICE

by
Lisa Taxier

A Thesis Submitted in
Partial Fulfillment of the
Requirements for the Degree of

Master of Science
in Psychology

at
The University of Wisconsin-Milwaukee
December 2018

ABSTRACT
DICKKOPF-1 BLOCKS 17β-ESTRADIOL-ENHANCED OBJECT MEMORY
CONSOLIDATION IN OVARIECTOMIZED FEMALE MICE
by
Lisa Taxier
The University of Wisconsin Milwaukee, 2018
Under the Supervision of Professor Karyn Frick
The memory-enhancing effects of 17β-estradiol (E2) are dependent upon rapid activation
of several cell signaling cascades within the dorsal hippocampus (DH). Among many cellsignaling pathways that mediate memory processes, Wnt/β-catenin signaling has emerged as a
potential key player. However, whether E2 interacts with Wnt/β-catenin signaling to promote
memory consolidation is unknown. Therefore, the present study examined whether Wnt/βcatenin signaling within the DH is necessary for E2-induced memory consolidation in both object
recognition and object placement tasks. Here, ovariectomized mice received immediate posttraining infusions of E2 or vehicle into the dorsal third ventricle plus the endogenous Wnt/βcatenin antagonist Dickkopf-1 (Dkk-1) or vehicle into the dorsal hippocampus to assess whether
the memory-enhancing effects of E2 depend on activation of Wnt/β-catenin signaling. Our results
suggest that Dkk-1 blocks E2-induced memory enhancement as hypothesized, but may operate in
an unexpected manner by only moderately blunting Wnt/β-catenin signaling while concurrently
activating Wnt/JNK signaling. The current study provides novel insight into the mechanisms by
which E2 enhances memory consolidation in the DH, as well as critical information about the
mechanistic actions of Dkk-1.
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Introduction
The sex steroid hormone 17β-estradiol (E2) is a robust positive mediator of hippocampal
plasticity and memory (Fernandez et al; 2008, Fortress et al, 2014; McClure et al, 2013; Woolley
et al, 1997; Zhao et al, 2010). However, the downstream mechanisms of E2-enhanced memory
processes still remain to be fully characterized. Our laboratory and others have demonstrated that
infusion of E2 into the female mouse dorsal hippocampus (DH) rapidly activates several cellsignaling cascades, including the extracellular signal-regulated kinase (ERK), mammalian target
of rapamycin (mTOR)-mediated protein synthesis, and phosphatidylinositol 3-kinase (PI3K)
pathways (Fernandez et al, 2008; Fan et al, 2010; Fortress et al, 2013b). Moreover, this
activation is necessary for E2 to facilitate object recognition and spatial memory consolidation in
ovariectomized (OVXed) female mice (Boulware et al., 2013; Fernandez et al, 2008; Fan et al,
2010, Kim et al, 2016), illustrating that rapid activation of DH cell signaling plays an essential
role in the memory-enhancing effects of E2. One cell signaling cascade that has been implicated
in memory processes is the Wnt/β-catenin, or canonical Wnt signaling pathway. Our laboratory
demonstrated that rapid activation of the Wnt/β-Catenin signaling pathway in the DH is critical
for object recognition memory consolidation in male mice, adding to a growing body of
literature implicating this pathway as an important mediator of memory processes (Fortress et al,
2013). However, estrogenic mediation of the Wnt/β-catenin signaling pathway has yet to be
examined in vivo as an important mediator of memory consolidation. The aim of the present
experiment was to examine whether the memory-enhancing effects of E2 are dependent upon
Wnt/β-catenin signaling pathway activation.
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Wnt signal transduction: an overview
The name “Wnt” comes from combining the gene wingless, identified in Drosophila and
important for cell polarity, with the homologous gene in vertebrates, integrated or int- 1(Nusse
and Varmus, 1982). The first identified Wnt molecule, Wnt1, was identified as a mediator of
mammary tumor development, and several other Wnt proteins were initially studied in the
context of both cancer pathology and embryonic development (Nusse and Varmus, 1982). There
are 19 identified discrete Wnt proteins, which act as extracellular glycoproteins that bind to the
seven transmembrane domain Frizzled (Fz) receptors to initiate downstream signaling. Within
the secretory pathway, Wnts are translated and targeted to the endoplasmic reticulum, where they
are eventually secreted in vesicles and trafficked to the extracellular space. Although not all of
the precise mechanisms of secretion, binding, and even manufacturing of specific Wnt proteins
have been elucidated, multiple researchers have demonstrated that two primary posttranslational
modifications, acylation and N-glycosylation, are important for Wnt protein function (Tang et al,
2012). Almost all Wnts are acylated by the acyltransferase Porcupine, which appends
palmitoleate while Wnts are in the endoplasmic reticulum (Langton et al, 2016). Furthermore,
lipidation of Wnts appears to be a critical modification that allows for interaction with the Fz
receptor (Langton et al, 2016). However, the ways in which these modifications and others may
contribute to Wnt action, and in which contexts, have yet to be fully characterized. For example,
lipidation, while critical for Wnt action on cell targets, may affect how far Wnts may travel in the
extracellular space, leading many researchers to posit that Wnts act primarily in short-range
signaling (Willert et al, 2003; Niehrs, 2010; Farin et al, 2016). Conversely, others have suggested
that Wnts may be able to bind to other molecules in the extracellular space that may affect
solubility and ability to exert longer-range signaling effects (Langton et al, 2016). More work
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remains in order to fully describe the process of Wnt secretion, beginning from the level of
synthesis and extending to characterizing how Wnts function in discrete environments.
Since the initial discovery of Wnt molecules in both Drosophila and vertebrates, an
expanding spectrum of roles for Wnt signaling has emerged. Our current knowledge of Wnts in
and outside of the nervous system includes roles for Wnt signaling in cell fate determination,
motility, and as it relates to the current work, memory processes (Komiya and Habas, 2008;
Fortress and Frick, 2015). Indeed, Wnt signaling is critical for normal hippocampal development,
and later on plays a key role in mediating synaptic plasticity, long-term potentiation, and
dendritic morphogenesis within the hippocampus (Lee et al, 2000; Chen et al, 2006; Dickins and
Salinas, 2013; Rosso et al, 2005). Although there are many signaling pathways involving Wnt
molecules, Wnt signaling is traditionally classified by three distinct pathways: the Wnt/planar
cell polarity (PCP) pathway, the Wnt/Calcium pathway, and the canonical or Wnt/β-catenin
signaling pathway.
Wnt/β-Catenin signaling
The most well known and well characterized Wnt signaling pathway is the Wnt/β-catenin
signaling pathway (Fig 1A). The functional result of this pathway, as its name suggests, is the
translocation of β-catenin into the cell nucleus, where it acts as a co-factor for existing nuclear
transcription factors, and facilitates gene transcription. When Wnt/β-catenin signaling is active,
Wnt ligands bind to Frizzled (Fz) receptors and low-density lipoprotein receptor-related protein 5
(LRP5) or LRP6 receptors, leading to the phosphorylation of glycogen synthase kinase-3 β
(GSK3β), which prevents the phosphorylation of β-catenin and allows it to accumulate and
translocate into the nucleus (Ciani and Salinas, 2005). In the nucleus, β-catenin binds to the
transcription factor TCF/LEF, which then increases expression of target genes including
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Fig 1. Wnt signaling is mediated by canonical and non-canonical pathways. (A)
Canonical Wnt/β-catenin signaling is activated when a canonical Wnt ligand binds to a
frizzled receptor and its co-receptor LRP 5/6. This leads Dishevelled (Dvl) to
phosphorylate GSK3β on Serine 9, which inactivates GSK3β. This inactivation decreases
phosphorylation of the transcriptional activator β-catenin, which then interacts with
TCF/LEF transcriptional complexes to increase expression of downstream target genes
such as Cyclin D1 and c-myc. (B) Wnt ligands binding to Fz receptors can also activate
the non-canonical Wnt/JNK or the Wnt/Calcium pathways. In the Wnt/JNK pathway,
activation of Dvl signals to Rho and Rac GTPases to activate ROCK and JNK,
respectively, to regulate cytoskeletal organization. In the Wnt/Calcium pathway, Gprotein mediated activation of phospholipase C increases diacylglycerol (DAG). The rise
in intracellular Ca2+ activates CaMKII and calcineurin to modulate transcriptional
activity through regulation of CREB and NFAT, respectively. DAG activates the enzyme
protein kinase C (PKC). Figure taken and adapted with permission from Fortress and
Frick, 2015.

Cyclin D1 and c-myc. In the absence of Wnt ligand binding to Fz or LRP5/6, GSK3β
phosphorylates β-catenin, allowing for ubiquitination and targeting β-catenin for proteosomal
degradation. Wnt/β-catenin signaling can also be inhibited by Dickkopf-1 (Dkk-1), an
endogenous protein that prevents Wnt ligands from complexing with Fz and LRP5/6 co	
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receptors (Bafico et al, 2001). The resulting unphosphorylated GSK3β then phosphorylates βcatenin, which is then degraded in the proteasome (Inestrosa & Arenas, 2010) so that it cannot
initiate gene transcription. Importantly, although Dkk-1 is traditionally thought of as a specific
antagonist of the Wnt/β-catenin signaling pathway, emergent evidence suggests a potential role
for Dkk-1 in altering signaling in non-canonical Wnt pathways. In fact, multiple researchers have
suggested that Dkk-1 binding to LRP5/6 may shift the balance away from Wnt/β-catenin
signaling by allowing other non-canonical Wnts to bind to the Frizzled receptor at the
membrane, effectively shifting the balance towards β-catenin-independent signaling (Endo et al,
2008; Caneparo et al, 2007).
β-Catenin-independent Wnt signaling pathways
Although Wnt/β-catenin signaling was the primary pathway of interest in the present
study, additional Wnt signaling pathways may also play an as of yet undescribed role in the
memory-enhancing effects of E2, and thus merit discussion. Furthermore, given evidence that
Dkk-1 may interact with β-Catenin-independent pathways, a description of key players in βCatenin-independent signaling is warranted. Here we will focus on describing the two other
primary Wnt signaling pathways, Wnt/PCP signaling and Wnt/Calcium signaling.
The Wnt/PCP signaling pathway, or as I will refer to it subsequently, the Wnt/JNK
pathway, plays a key role in regulating cytoskeletal dynamics and cell polarity. This pathway
was initially described as a critical signaling event that allowed for planar, organized cellular
activity (thus the term planar cell polarity), such as orientation of fly wing hairs or sensory hair
cells in the mammalian inner ear (Boutros et al, 1998; Shulman et al, 1998). In mammalian
systems, Wnt/JNK signaling is largely homologous to Wnt/PCP signaling. In this pathway,
instead of complexing with LRP5/6, the Fz receptor instead complexes with co-receptors such as
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RYK or MUSK (Nierhs, 2012). The Fz/co-receptor complex then activates Dvl, which signals to
monomeric GTPases Rho and Rac. Rho then stimulates ROCK, while Rac activates JNK to
ultimately regulate downstream target genes involved in cytoskeletal dynamics (Olivia et al,
2013; Rosso and Inestrosa, 2013; Fig 1B). Importantly, although Dkk-1 is thought to be a Wnt/βcatenin signaling antagonist, recent evidence suggests that Wnt/JNK signaling may also be
targeted by Dkk-1. For example, one recent study describes synapse disassembly mediated by
Dkk-1 activation of Wnt/JNK signaling (Marzo et al, 2016). Although the mechanism through
which Dkk-1 interacts with Wnt/JNK signaling is unclear, it may be the case that Dkk-1 shifts
the balance away from Wnt/β-catenin signaling activity towards Wnt/JNK signaling activity.
The third primary Wnt signaling pathway, and the second primary non-canonical Wnt
signaling pathway, is the Wnt/Calcium signaling pathway (Fig 1B). Here, as its name suggests,
the net result of signaling activation is an increase in intracellular calcium activity, and a
resulting change in transcriptional activity through transcription factors such as CREB. As in
both Wnt/β-catenin signaling and Wnt/JNK signaling, Wnts bind to membrane Fz receptors and
initiate a signal cascade through Dvl (Slularski et al, 1997). When this signaling pathway is “on,”
phospholipase C is activated, resulting in increased intracellular Ca2+, which allows for
subsequent increases in diacylglycerol, calcineurin and Ca2+/calmodulin dependent protein
kinase II (CaMKII). Protein kinase C is also activated, which potentiates intracellular Ca2+
increases (Niehrs 2012, Hogan et al 2003). The primary function of this pathway is thought to be
related to axon guidance, although several researchers have also demonstrated a role for this
pathway in regulating synaptic plasticity (McQuate et al, 2017; Wayman et al, 2006).

	
  

6	
  

Wnt/β-Catenin signaling and memory processes
Increasing evidence suggests that the Wnt/β-catenin signaling pathway plays an
important role in learning and memory processes, especially within the hippocampus. For
instance, spatial learning in the Morris water maze increases levels of the canonical Wnt proteins
Wnt7a/b in area CA3 of the hippocampus in male rats (Tabatadze et al, 2012). In addition,
contextual fear conditioning increases expression of Wnt3a, whereas intrahippocampal infusion
of a Wnt3a antibody impairs both the acquisition and consolidation phases of contextual fear
conditioning, but not the expression phase (Xu et al, 2015). Wnt7a/b is increased in hippocampal
cell bodies and is subsequently trafficked to dendrites after glutamate activation, suggesting a
role for canonical Wnts in regulating synaptic plasticity (Tabatadze et al, 2014). Notably,
expression of the Wnt antagonist Dickkopf-1 (Dkk-1) within the brain increases with age in both
rodents and humans. However, knockout of Dkk-1 in the aging mouse hippocampus increases
neurogenesis and facilitates spatial memory consolidation (Seib et al, 2013). These data
implicate a role for dysfunctional Wnt/β-catenin signaling in cognitive aging. Our laboratory has
shown that blockade of Wnt/β-catenin signaling with Dkk-1 prevents memory consolidation in
an object recognition task in male mice (Fortress et al, 2013). Conversely, activation of Wnt
signaling in vivo with Wnt-activating small molecule (WASP-1) enhances episodic memory on a
memory flexibility task in the water maze, and concurrently increases basal excitatory synaptic
transmission and facilitates LTP in adult mice (Vargas et al, 2015). Combined, these data
demonstrate the involvement of Wnt/β-catenin signaling in memory processes.
E2, cell signaling, and memory processes
Our laboratory has demonstrated repeatedly that DH infusion of E2 in OVXed female
mice activates multiple cell-signaling pathways within 5 min in the DH that regulate learning and
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memory processes, such as the extracellular signal-regulated kinase (ERK) pathway, mammalian
target of rapamycin (mTOR)-mediated protein synthesis, and phosphatidylinositol 3-kinase
(PI3K) cascades (Fernandez et al, 2008; Fan et al, 2010; Fortress et al, 2013b). Moreover, this
activation is necessary for E2 to facilitate object recognition and spatial memory consolidation in
OVXed female mice (Boulware et al., 2013; Fernandez et al, 2008; Fan et al, 2010, Kim et al,
2016), illustrating that rapid activation of DH cell signaling plays an essential role in the
memory-enhancing effects of E2.
The above-described rapid effects of E2 on cell-signaling activation in the DH occur
within seconds to minutes, and are mediated by E2 binding to membrane-bound estrogen
receptors (ERs) or ERs in close proximity to the cell membrane. Conversely, non-classical
effects, which occur within hours or days, are mediated by a complex containing E2 and an
estrogen receptor (ER) binding to an estrogen response element on DNA, which leads to changes
in gene expression. Among the most well-characterized estrogen receptors are ERα, ERβ, and G
protein-coupled estrogen receptor (GPER). Intracellular receptors ERα and ERβ are known to
mediate classical effects of E2 within the DH, whereas GPER, which is present within cell
membranes, is less well characterized. However, recent data from our lab suggest that activation
of hippocampal GPERs enhances OR and OP memory in ovariectomized females (Kim et al,
2016). Interestingly, GPER-mediated memory enhancement appears to occur independently of
E2, and instead depends upon JNK activation.
Wnt/β-Catenin signaling and E2 interactions
Although our laboratory has demonstrated the critical importance of Wnt/β-catenin
signaling for object recognition in male mice, the putative role of Wnt/β-Catenin signaling in
mediating the mnemonic effects of E2 is unknown. However, evidence from multiple studies
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suggests that E2 may activate Wnt/β-catenin signaling. For instance, E2 serves a neuroprotective
function in animal models of cerebral ischemia by downregulating Dkk-1, which is usually
present in abnormally high amounts in ischemia models, in area CA1 of the mouse hippocampus
(Zhang et al, 2008). Furthermore, E2 increases levels of Wnt3a, a canonical Wnt ligand, in area
CA1 of the hippocampus following experimental induction of cerebral ischemia in mice (Zhang
et al, 2008). Estrogen receptor α (ERα) also complexes with GSK3β and β-catenin in the
hippocampus. In the presence of E2, β-catenin dissociates from this complex, presumably
allowing it to act downstream to increase transcription of Wnt/β-catenin target genes (CardonaGomez, 2003). Further, Cardona-Gomez et al (2004) demonstrate that ovariectomized female
rats treated with E2 exhibit a transient increase in phosphorylated hippocampal GSK3β, further
cementing a role for E2 in activating Wnt/β-catenin signaling. Another study suggests a role for
E2 in mediating the interaction between the estrogen receptor coregulator protein Proline-,
glutamic acid-, and leucine-rich protein 1 (PELP1) and the phosphorylation of GSK3β (Sareddy
et al, 2015). Interestingly, the E2-induced increase in phosphorylation of GSK3β does not occur
in PELP1 knockout mice, suggesting that PELP1 is critical for the E2-mediated increase in
GSK3β phosphorylation (Sareddy et al, 2015). Together, these data suggest a potential role for
E2 in mediating Wnt/β-catenin signaling. However, evidence describing the extent to which E2
activates this pathway to promote memory consolidation is lacking.
Therefore, the present study investigated whether Wnt/β-catenin signaling is necessary
for the memory-enhancing effects of E2 previously observed in OVXed mice (Fernandez et al.,
2008; Fortress et al., 2013; Boulware et al., 2013; Kim et al., 2016). Mice received bilateral DH
infusion of Dkk-1 immediately after training in object recognition and object placement tasks,
concurrent with intracerebroventricular (ICV) infusion of E2. Our findings suggest that Dkk-1
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prevents E2 from enhancing object recognition and spatial memory consolidation in OVXed mice
via modest blockade of Wnt/β-catenin signaling and concurrent activation of Wnt/JNK signaling.

Methods
Subjects
Female C57BL/6 mice aged 8-10 weeks (Charles River, Wilmington, MA) were used for
all studies. Mice were housed in groups of up to 5/cage until 24 h prior to surgery, at which time
they were singly housed. Mice were maintained on a 12 h light/dark cycle with ad libitum access
to food and water. All experimental protocols and procedures were approved by the University
of Wisconsin-Milwaukee Institutional Animal Care and Use Committee and are in accordance
with National Institutes of Health guidelines or Guide for the Care and use of Laboratory
Animals.
General experimental design
Three days after arrival in the lab, mice were ovariectomized and implanted with guide
cannulae aimed at the dorsal hippocampus and dorsal third ventricle. Following a recovery
period of one week, mice underwent behavioral training and testing in an object recognition
(OR) task to measure object recognition memory and an object placement (OP) task to measure
spatial memory. Unique sets of objects were used for each task. The order of testing in each task
was counterbalanced across groups and separated by two weeks to allow the hippocampus to
recover from infusion. Two weeks following completion of behavioral testing, mice were reinfused and dorsal hippocampi were collected at various time points following infusion for
Western blotting experiments.
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Surgery
All surgeries were conducted starting 3 days after arrival in the laboratory as described
previously (Boulware et al., 2013; Fortress et al., 2013). Mice were anesthetized with isoflurane
(5% for induction, 2% for maintenance) in 100% oxygen and placed in a stereotaxic apparatus
(Kopf Instruments, Tujunga, CA) from which they underwent ovariectomy and cannula
implantation in the same surgical session as described previously (Boulware et al., 2013; Fortress
et al., 2013). For initial experiments using single drugs (e.g. Dkk-1), mice were implanted with
double guide cannulae (Plastics One, Roanoke, VA) aimed bilaterally at the dorsal hippocampus
(DH; C232GC, 22 gauge; −1.7 mm AP, ±1.5 mm ML, and −2.3 mm DV). For experiments using
concurrent infusion of E2 and Dkk-1, mice were implanted with three stainless steel guide
cannulae aimed at the dorsal third ventricle (ICV; C232GC, 22 gauge; −0.9 mm AP, ± 0.0 mm
ML, and −2.8 mm DV) and both sides of the DH as described above. Cannulae were fixed to the
skull with dental cement (Darby Dental Supply, New York, NY) that served to close the wound.
Dummy cannulae (C232DC; Plastics One) were inserted into each cannula to prevent clogging
of the cannula tracts. Mice were given at least one week prior to the start of behavioral testing.
Drugs and infusions
The Wnt/β-catenin inhibitor Dickkopf-1 (Dkk-1) was dissolved in sterile 0.9% saline to a
concentration of 5 ng/µl. A volume of 0.5 µl Dkk-1 or saline vehicle was infused bilaterally into
each side of the DH at a rate of 0.5 µl/min for 1 min per hemisphere immediately following
training in OR and OP. Cyclodextrin-encapsulated E2 (Sigma-Aldrich, St. Louis, MO) was
dissolved in sterile 0.9% saline to a concentration of 10 µg/µl. The vehicle consisted of 2hydoxypropyl-β-cyclodextrin (HBC; Sigma-Aldrich, St. Louis, MO) dissolved in saline to the
same concentration of cyclodextrin present in the cyclodextrin-encapsulated E2 solution. A total
volume of 1 µl E2 or HBC was infused into the dorsal third ventricle at a rate of 0.5 µl/min for 2
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min to allow for the same total volume as DH infusions at the same rate. This triple infusion
protocol is routinely used by our lab to prevent potential damage to the DH from two infusions
into the DH in rapid succession (Fernandez et al., 2008; Fan et al., 2010; Zhao et al., 2010, 2012;
Boulware et al., 2013; Fortress et al., 2013). Here, we used triple cannulae to administer E2 into
the dorsal third ventricle adjacent to the DH while infusing Dkk-1 bilaterally into the DH. This
protocol avoids potential damage to the DH from infusions of both compounds, and precludes
possible interactions between the drugs within the DH and reduced drug efficacy that could
result from the dilution of each drug in the larger ICV infusion volume.
Behavioral testing
Object recognition (OR) and object placement (OP) were used to measure object
recognition and spatial memory as we have previously described (Fernandez et al., 2008;
Fortress et al., 2013; Boulware et al., 2013; Kim et al., 2016; Tuscher et al., 2016). Mice were
handled for 30 sec/day for three days prior to habituation. On the second day of handing, a Lego
was placed in each home cage to habituate mice to objects during remaining days of handling
and habituation. After three days of handling, mice were habituated to the empty testing
apparatus (60 cm x 60 cm x 47 cm) for 5 min/day for two consecutive days. The next day, mice
were habituated to the empty arena for 2 min prior to training with objects, removed from the
arena and placed in a holding cage, and then placed back into the arena with two identical objects
placed 5 cm from the upper left and right corners of the arena. Mice were then allowed to
explore the objects until they had accumulated 30 sec of exploration time or until 20 min had
elapsed. Immediately following training, mice received DH or DH+ICV drug infusions and were
returned to their home cage. Conducting infusions immediately post-training allowed us to
establish the effects of E2 and/or Dkk-1 specifically on memory consolidation in the absence of
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confounding effects on non-mnemonic performance factors (e.g., motivation, sensorimotor
abilities) (Gresack and Frick, 2006; Fernandez et al., 2008). During OR testing, mice were
returned to the arena and allowed to accumulate 30 s exploring one object that was identical to
those used during training and a novel object. The location of the objects remained the same as
during training. Mice that remember the identity of the training objects will spend more time
than chance (15 s) exploring the novel object during testing, whereas mice that do not will not
explore the novel object more than chance (Frick and Gresack, 2003). During OP testing, mice
were allowed to explore objects identical to those used in training, however, one object was
moved to a lower corner of the arena. Mice that remember the location of the training objects
will spend more time than chance (15 s) exploring the moved object during testing (Boulware et
al., 2013; Kim et al., 2016). For all experiments, time spent with the objects was recorded using
ANYmaze software (Stoelting).
In our first experiment, testing was conducted 24 h after training for OR and 4 h after
training for OP to determine a dose of Dkk-1 that did not impair memory consolidation on its
own. The 24- and 4-h time points were used because vehicle-treated OVXed females have intact
memory for a novel object and moved object, respectively, at these delays (Gresack et al., 2007;
Boulware et al., 2013; Fortress et al., 2013; Pereira et al., 2014; Kim et al., 2016; Kim and Frick,
2017). After determining a dose of Dkk-1 that did not impair memory on its own, delays of 48
and 24 h were used subsequently for OR and OP, respectively, because vehicle-infused OVXed
females show impaired OR and OP memory, whereas E2-treated OVXed females show intact OR
and OP memory, at these delays (Gresack et al., 2007; Boulware et al., 2013; Fortress et al.,
2013; Pereira et al., 2014; Kim et al., 2016; Kim and Frick, 2017).
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Western blotting
Western blotting was conducted as described previously (Fernandez et al, 2008;
Boulware et al, 2013). To determine the effects of Dkk-1 on E2-mediated cell-signaling, mice
received infusions as described above and were then cervically dislocated and decapitated 5 or
45 min later. The DH was immediately dissected bilaterally and frozen at -80°C until
homogenized. Briefly, tissue samples were resuspended 1:25 w/v in lysis buffer and
homogenized using a probe sonicator (Branson Sonifier 250). Homogenates were
electrophoresed on TGX (Tris-Glycine eXtended) stain-free precast gels (Bio-Rad) and
transferred to polyvinylidene fluoride (PVDF) membranes using the TransBlot Turbo system
(Bio-Rad). Membranes were blocked with 5% milk and incubated with primary antibodies
(phospho-GSK3β, phospho-ERK, c-myc, phospho-JNK, synaptophysin, phospho-PKC, active βCatenin 1:1000, Cell Signaling Technology; Wnt7a, 1:1000, abcam) overnight at 4°C. The
following day, blots were incubated for 1 h at room temperature with a rabbit HRP-conjugated
secondary antibody (1:5000, Cell Signaling Technology), and developed using West Dura
chemiluminescent substrate (Pierce). A ChemiDoc MP gel imager (Bio-Rad) was used to detect
signal correlating with protein expression, and densitometry was performed using Image Lab
software (Bio-Rad). Protein expression was normalized to total membrane-bound protein
expression, and data were represented as percent immunoreactivity relative to vehicle controls.
Treatment effects were measured within single gels (n=6-8/group).
Data analysis
All statistical analyses were conducted using GraphPad Prism 6 (La Jolla, CA). To
determine whether each group demonstrated intact memory consolidation for each task, OR and
OP data were first analyzed using one-sample t-tests to determine whether time spent with the
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novel or moved object differed significantly from chance (15 s; Boulware et al., 2013; Kim et al.,
2016; Tuscher et al., 2016; Kim et al, 2017). This analysis was used because time spent with the
objects is not independent; time spent with one object necessarily reduces time spent with the
other (Frick and Gresack 2003). To assess between-group treatment effects within each
behavioral experiment, one-way ANOVAs with treatment as the independent variable were
conducted, followed by Fisher’s LSD post hoc tests. Western blot data were analyzed using oneway ANOVAs followed by Fisher’s LSD post hoc tests and selected t-tests. Statistical
significance was determined at p < 0.05. Effect sizes were calculated using η2 for ANOVAs
(sum of squares between/sum of squares total) and Cohen’s d (mean of differences/standard
deviation of differences) for pair-wise comparisons.

Results
Dkk-1 blocks object recognition memory consolidation
Although we previously established that DH infusion of Dkk-1 prevents memory
consolidation in an object recognition task in male mice (Fortress et al, 2013), here we aimed to
determine: 1) whether Wnt/β-catenin signaling is necessary for memory consolidation in
ovariectomized female mice, and 2) a dose of Dkk-1 that does not impair memory on its own.
Identification of a behaviorally subeffective dose of Dkk-1 was necessary to ensure that any
impairment seen after Dkk-1+E2 infusion in subsequent experiments resulted from an interaction
between Dkk-1 and E2 rather than a general memory-impairing effect of Dkk-1 alone. Young
female mice (n = 8-12/group) were OVXed and implanted with cannula aimed at the bilateral
DH. Immediately after object recognition training, mice received bilateral DH infusion of vehicle
(saline, n=8-10 per group), 1 ng (n=8), 5 ng (n=12), or 10 ng/hemisphere (n=12) of Dkk-1.
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Twenty-four hours later, mice receiving vehicle (t(9) = 2.412, p = 0.0391, d = 0.763; t(8) = 4.704,
p = 0.0015, d = 1.569; t(7) = 3.626, p = 0.0084, d = 1.284), 1 ng (t(6) = 3.516, p = 0.0126, d =
1.327), or 5 ng/hemisphere (t(11) = 2.790, p = 0.0176, d = 0.805) of Dkk-1 spent significantly
more time than chance (15 s) with the novel object, indicating intact OR memory consolidation
(Fig 2A). Conversely, mice receiving 10 ng/hemisphere of Dkk-1 did not spend significantly
more time than chance with the novel object, indicating impaired OR memory consolidation (p =
0.1522). Similar results were observed for OP (Fig 2B). Four hours after training, mice infused
with vehicle (n=9; t(8) = 3.232, p = 0.0120, d = 1.077) or 5 ng/hemisphere of Dkk-1 (n=12; t(11) =
2.675, p = 0.0216, d = 0.772) spent significantly more time than chance with the moved object.
These results demonstrate that 5 ng/hemisphere Dkk-1 does not block memory consolidation in
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   2.	
   5ng/hemisphere	
   Dkk-‐1	
   does	
   not	
   impair	
   object	
   recognition	
   or	
   object	
   placement	
  
memory	
   consolidation.	
   (A)	
   Twenty-‐four	
  hours	
  after	
  training,	
  mice	
  receiving	
  DH	
  infusion	
  
of	
   vehicle,	
   1ng/hemisphere	
   of	
   Dkk-‐1,	
   and	
   5	
   ng/hemisphere	
   of	
   Dkk-‐1	
   spent	
   significantly	
  
more	
   time	
   with	
   the	
   novel	
   object	
   than	
   chance	
   (dashed	
   line	
   at	
   15	
   s)	
   and	
   than	
   all	
   other	
  
groups.	
   (B)	
   Four	
   hours	
   after	
   training,	
   mice	
   receiving	
   DH	
   infusion	
   of	
   vehicle	
   or	
   5	
  
ng/hemisphere	
  of	
  Dkk-‐1	
  spent	
  significantly	
  more	
  time	
  with	
  the	
  novel	
  object	
  than	
  chance	
  
(*p	
  <	
  0.05).	
  *p	
  <	
  0.05	
  relative	
  to	
  chance.	
  Bars	
  represent	
  the	
  mean	
  ±	
  standard	
  error	
  of	
  the	
  
mean	
  (SEM).	
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experiments with E2.
Dkk-1 blocks the memory-enhancing effects of E2 on object recognition and object placement
memory consolidation
To determine whether Wnt/β-catenin signaling is necessary for the memory-enhancing
effects of E2, young female mice were OVXed and implanted with DH and ICV cannulae.
Immediately after OR training, mice received bilateral DH infusion of vehicle or 5
ng/hemisphere Dkk-1, followed by ICV infusion of vehicle or E2 (10 µg). Forty-eight hours later,
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Fig.	
   3.	
   Dkk-‐1	
   blocks	
   E2-‐mediated	
   memory	
   enhancement.	
   (A)	
   Forty-‐eight	
   hours	
   after	
  
training,	
   mice	
   receiving	
   DH	
   infusion	
   of	
   vehicle	
   and	
   ICV	
   infusion	
   of	
   E2	
   spent	
   significantly	
  
more	
  time	
  with	
  the	
  novel	
  object	
  than	
  chance	
  (dashed	
  line	
  at	
  15	
  s)	
  and	
  than	
  all	
  other	
  groups	
  
(Veh+Veh,	
  n	
  =	
  15;	
  Dkk-‐1+Veh,	
  n	
  =	
  20,	
  Veh+E2,	
  n	
  =	
  20,	
  Dkk-‐1+E2,	
  n	
  =	
  22).	
  (B)	
  Twenty-‐four	
  
hours	
   after	
   training,	
   mice	
   receiving	
   Veh+E2	
   spent	
   significantly	
   more	
   time	
   with	
   the	
   novel	
  
object	
   than	
   chance	
  (*p	
  <	
   0.05)	
  and	
   than	
   all	
   other	
   groups	
   (Veh+Veh,	
   n	
   =	
   18;	
   Dkk-‐1+Veh,	
   n	
   =	
  
20,	
  Veh+E2,	
   n	
  =	
   20,	
   Dkk-‐1+E2,	
   n	
  =	
   22).	
   *p	
   <	
  0.05	
  relative	
  to	
  chance;	
  #p	
  <	
  0.05	
  relative	
  to	
  the	
  
Veh+E2	
  group.	
  Bars	
  represent	
  the	
  mean	
  ±	
  standard	
  error	
  of	
  the	
  mean	
  (SEM).	
  	
  
mice receiving infusions of vehicle+vehicle (n=15), Dkk-1+vehicle (n=20), or Dkk-1+E2 (n= 22)
spent no more time than chance (15 s) with the novel object, indicating impaired OR memory
consolidation. In contrast, mice receiving infusions of vehicle+E2 (n=20) spent significantly
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more time than chance with the novel object (t(19) =5.358, p < 0.0001, d = 1.200; Fig. 3A),
demonstrating intact OR memory consolidation. This pattern of significance suggests that Dkk-1
blocked the memory-enhancing effects of E2. This conclusion is supported by the one-way
ANOVA, in which the main effect of treatment was significant (F(3,73) = 3.161, p = 0.0296, η2 =
0.1149; Fig 3A) and post hoc tests revealed that mice infused with vehicle+E2 spent significantly
more time with the novel object than all other groups. Similar results were observed for OP.
Twenty-four hours after training, mice infused with vehicle+vehicle (n=18), Dkk-1+vehicle
(n=20), or Dkk-1+E2 (n=22) spent no more time than chance (15 s) with the moved object,
whereas mice receiving vehicle+E2 (n=20) spent significantly more time than chance with the
moved object (t(19) =5.154, p < 0.0001; Fig. 3B). Again, the one-way ANOVA indicated a
significant main effect of treatment (F(3,76) = 3.604, p = 0.0171, η2 = 0.1246; Fig 3B) and post
hoc tests revealed that mice infused with vehicle+E2 spent significantly more time with the
moved object than all other groups. Collectively, these results demonstrate that Dkk-1 prevented
E2 from enhancing consolidation in both OR and OP.
Dkk-1 modulates changes in Wnt/β-catenin signaling proteins
Our behavioral data indicate a role for Wnt/β-catenin signaling in E2-induced memory
consolidation. Therefore, we next examined the effects of E2 and Dkk-1 on Wnt/β-catenin
signaling in the DH. Specifically, we hypothesized that E2 would activate Wnt/β-catenin
signaling, and Dkk-1 would block this activation. Two weeks after the conclusion of behavioral
testing, mice tested above were infused a final time with vehicle+vehicle, Dkk-1+vehicle,
vehicle+E2, or Dkk-1+E2 as described above. DH tissue was collected 5 or 45 min later for
analysis of total β-catenin, phospho-GSK3β, c-myc, and Wnt7a protein levels. We also assayed

	
  

18	
  

v/E2

A

B

p42

150

*

100

50

0

Veh+Veh

Veh+E2

C

Dkk1+Veh Dkk1+E2

150

*

v/E2

Veh+E2

Dkk1/v Dkk1/E2

*
50

0

Veh+Veh

Veh+E2

*

v/E2

Dkk1/v Dkk1/E2

150

100

50

0

Dkk1+Veh Dkk1+E2

Dkk1+Veh Dkk1+E2

v/v

D

50

Veh+Veh

v/E2

100

Dkk1/v Dkk1/E2

100

0

v/v

150
c-myc immunoreactivity (%)

*

v/v

phospho-GSK3b (s9) immunoreactivity (%)

Dkk1/v Dkk1/E2

Wnt7a immunoreactivity (%)

phospho-ERK (p42) immunoreactivity (%)

v/v
p44

Veh+Veh

Veh+E2

Dkk1+veh

Dkk1+E2

Fig.	
   4.	
  Expression	
   of	
   Wnt/β-‐catenin	
  signaling	
  proteins	
  is	
  influenced	
  5	
  min	
  (A,	
  B)	
  and	
   45	
  
min	
   (C,	
  D)	
  following	
  Dkk-‐1	
  and	
  E2	
  infusion.	
  (A)	
  Intracerebroventricular	
  (ICV)	
  infusion	
  of	
  
E2	
  (5	
  μg/hemisphere)	
  increased	
  levels	
  of	
  phosphorylated	
  p42	
  ERK	
  5	
  min	
  post-‐infusion,	
  an	
  
effect	
   that	
   was	
   not	
  blocked	
  by	
   DH	
   infusion	
   of	
   Dkk-‐1.	
   (B)	
   c-‐myc	
   levels	
   were	
   reduced	
   5	
   min	
  
following	
   DH	
   infusion	
   of	
   Dkk-‐1.	
   (C)	
   Levels	
   of	
   phosphorylated	
   GSK3β	
   were	
   increased	
   45	
  
min	
   after	
   ICV	
  infusion	
  of	
  E2,	
   an	
  effect	
  not	
  blocked	
  by	
  DH	
  infusion	
  of	
  Dkk-‐1.	
  (D)	
  Levels	
  of	
  
Wnt7a	
  protein	
  were	
  decreased	
  45	
  min	
  after	
  DH	
  infusion	
  of	
  Dkk-‐1.	
  Each	
  bar	
  represents	
  the	
  
mean	
  ±	
  SEM	
  percent	
  change	
  from	
  vehicle	
  (*p	
  <	
  0.05).	
  
levels of phospho-p42 ERK and phospho-p44 ERK protein as positive and negative controls for
E2-induced activation of hippocampal cell signaling. Our previous work shows that E2
selectively increases phospho-p42 ERK levels 5 min after DH or ICV infusion (Fernandez et al.,
2008; Boulware et al., 2013; Fortress et al., 2013; Kim et al., 2016). Consistent with these
reports, ICV infusion of E2 increased phospho-p42 ERK levels (F(3,28) = 4.335, p < 0.05, η2 =
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0.3171; Fig. 4A), but not phospho-p44 ERK levels (F(3,28) = 0.9495, p = 0.4301; data not shown)
5 min post-infusion. This effect was not blocked by DH infusion of Dkk-1, potentially
suggesting no E2-induced interaction between the Wnt/β-catenin and ERK signaling pathways.
Interestingly, E2 increased phospho-GSK3β levels 45 min post-infusion (F(3,30) = 3.257, p < .05,
η2 = .2457; Fig 4C), but this was also not blocked by Dkk-1. Even more peculiarly, E2 had no
effect on levels of c-myc 5 min after infusion or on Wnt7a 45 min after infusion. However, the
behaviorally sub-effective dose of Dkk-1 used for our behavioral experiments reduced c-myc
protein levels sufficiently to produce a main effect of treatment (F(3,25) = 3.411, p < 0.05, η2 =
.2905; Fig 4B), in which levels were significantly reduced relative to vehicle+vehicle. A similar
pattern was evident for Wnt7a protein 45 min post infusion but the main effect of treatment was
not significant (F(3,20) = 1.483, p =.2494; Fig 4D). Importantly, levels of β-catenin protein
remained unchanged in any treatment group at either time point (data not shown). Together,
these data suggest only a modest activation of	
   Wnt/β-catenin signaling by E2, but curiously,
indicate that Dkk-1 may not block E2-induced memory enhancement in a β-catenin-dependent
manner.
Dkk-1 modulates changes in non-canonical Wnt signaling proteins
Given the above findings, we expanded our search of biochemical changes underlying the
above-described behavioral effects to include targets of β-catenin-independent pathways,
Wnt/JNK, and Wnt/Calcium signaling. We examined levels of phosphorylated p46 JNK protein
and a downstream target of Wnt/JNK activity, synaptophysin. In addition, we assessed levels of
phosphorylated PKC protein, a marker of Wnt/Calcium signaling. Our rationale for examining
these pathways comes from evidence suggesting that Dkk-1 may activate Wnt/JNK signaling
(Kilick et al, 2014; Lee et al, 2004), as well as data indicating a potential role for noncanonical

	
  

20	
  

Dkk1/v Dkk1/E2

100

50

0

*

A

* Dkk1/v Dkk1/E

2

*

*

150

Synaptophysin immunoreactivity (%)

150

v/E2

100

50

Veh+Veh

0

Veh+E2

Veh+Veh

Dkk-1+Veh Dkk-1+E2

Veh+E2

0

50

0

v/E2

Dkk1/v Dkk1/E2

v/E2

Dkk1/v Dkk1/E2

150

*
100

*

50

Veh+Veh

0

Veh+E2

Veh+Veh

Dkk1+Veh

Veh+E2

Dkk1+E2

Dkk1+Veh

Dkk1+E2

Dkk1/v Dkk1/E2

v/E2

Dkk1/v Dkk1/E2

*

*

150

v/E2

v/v

B

*

*

C

150

50

100

v/v

p-PKC immunoreactivity (%)

p-PKC immunoreactivity (%)

C

100

150

Dkk-1+Veh Dkk-1+E2
v/v

v/v

B
Synaptophysin immunoreactivity (%)

v/E2

v/v

phospho p-46 JNK immunoreactivity (%)

phospho p-46 JNK immunoreactivity (%)

v/v

A

100

50

Veh+Veh

0

Veh+E2

Veh+Veh

Dkk-1+Veh Dkk-1+E2

Veh+E2

Dkk-1+Veh Dkk-1+E2

Fig.	
   5.	
  Expression	
  of	
  Wnt/JNK	
  signaling	
  proteins	
  is	
  influenced	
  5	
  min	
  after	
  Dkk-‐1	
  and	
  E2	
  
infusion.	
  (A)	
  Dorsal	
  hippocampal	
  infusion	
  of	
  Dkk-‐1	
  increased	
  levels	
  of	
  phospho-‐JNK	
  5	
  min	
  
after	
   infusion,	
   regardless	
   of	
   whether	
   vehicle	
   or	
   E2	
   was	
   infused	
   ICV.	
   (B)	
   Synaptophysin	
  
levels	
   were	
  decreased	
  5	
  min	
  after	
  DH	
  infusion	
   of	
  Dkk-‐1.	
   (C)	
   Levels	
  of	
  phospho-‐PKC	
   were	
  
increased	
   5	
   min	
   after	
   ICV	
   infusion	
   of	
   E2,	
   regardless	
   of	
   whether	
   vehicle	
   or	
   Dkk-‐1	
   was	
  
infused	
  into	
  the	
  DH.	
  Each	
  bar	
  represents	
  the	
  mean	
  ±	
  SEM	
  percent	
  change	
  from	
  vehicle	
  (*p	
  
<	
  0.05).	
  
	
  
Wnt signaling in antagonizing Wnt/β-catenin signaling (Topol et al, 2003). The main effect of
treatment was significant for phospho-p46 JNK (F(3,32) =5.069, p < 0.01, η2 = .3222; Fig 5A),
such that levels 5 min post-infusion were significantly increased relative to vehicle+vehicle in
both groups receiving Dkk-1. Synaptophysin levels were significantly affected by treatment
(F(3,28) = 5.250, p < 0.01, η2 = .3600; Fig 5B), such that infusion of Dkk-1+vehicle significantly
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decreased synaptophysin levels relative to vehicle 45 min post-infusion (p < 0.05). E2 appeared
to mitigate this decrease, as levels in the Dkk-1+E2 group did not differ from vehicle.
Phosphorylated PKC protein expression was significantly increased 5 min following E2 infusion
(F(3,18) = 3.381, p < 0.05; η2 = .3604, Fig 5C), an effect which was not blocked by Dkk-1. These
data indicate that Dkk-1 may interface with Wnt/JNK signaling in the hippocampus, but not with
Wnt/Calcium signaling.

Discussion
Previous work from our lab and others has demonstrated that Wnt/β-catenin signaling
plays a critical role in hippocampal memory processes (Fortress et al, 2013; Maguschak and
Ressler, 2011). Moreover, a role for E2 in rapidly activating cell signaling within the DH to
mediate memory consolidation has been repeatedly reported (Fernandez et al, 2008; Fan et al,
2010). However, the present study is the first to demonstrate that E2-mediated memory
enhancement involves Wnt signaling. First, we demonstrated that DH infusion of the endogenous
Wnt signaling antagonist Dkk-1 prevents E2-mediated memory enhancement. Second, we
showed that this behavioral effect is accompanied by suppression of specific elements of Wnt/βcatenin signaling, and activation of Wnt/JNK signaling. Collectively, our results provide novel
insight into the pathways through which E2 works to mediate memory processes within the
female mouse DH.
Our data demonstrating that DH infusion of Dkk-1 blocks the memory-enhancing effects
of E2 in OVXed mice is consistent with and extends our previous report that Dkk-1 prevents
object recognition memory consolidation in male mice (Fortress et al, 2013). Our previous work
involved DH infusion of a 10-fold higher dose (50 ng/hemisphere) of Dkk-1 than the current
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study. Here, we aimed to determine whether inhibition of Wnt/β-catenin signaling could block
the memory enhancing effects of E2. In our first experiment, we found that even a
10ng/hemisphere dose of Dkk-1 could impair object recognition memory consolidation.
Therefore, we used a lower dose of Dkk-1 no effects on memory (5 ng/hemisphere) to determine
whether Dkk-1 interferes with the memory-enhancing effects of E2. As predicted, Dkk-1 did
prevent E2 from enhancing both object recognition and object placement memory consolidation.
This result is consistent with data demonstrating that ICV injection of Dkk-1 reverses the
neuroprotective effects of E2 in the female hippocampus (Scott and Brann, 2013), and extend
these findings to show a novel role for Dkk-1 in preventing E2-induced memory enhancement
among normal females.
Because Dkk-1 is a known antagonist of Wnt/β-catenin signaling, we hypothesized that it
blocked the memory-enhancing effects of E2 by turning “off” Wnt/β-catenin signaling, and thus
would prevent E2 from increasing hippocampal levels of phospho-GSK3β, β-catenin, c-myc, and
Wnt7a protein. However, we were surprised to find only modest suppression of Wnt/β-catenin
signaling proteins. Although our data indicating that DH infusion of Dkk-1 suppresses levels of
c-myc and Wnt7a proteins are consistent with our hypothesis, there was no E2-mediated increase
in these proteins, suggesting that Dkk-1 may actually block memory consolidation through
alternative, non-canonical pathways, and that E2 may not robustly activate Wnt/β-catenin
signaling as expected. Indeed, the lack of E2-mediated increases in Wnt/β-catenin signaling
proteins, with the exception of phosphorylated GSK3β, suggests that E2 may not enhance
memory through direct activation of Wnt/β-catenin signaling. Our data describing an E2mediated increase in phosphorylated GSK3β protein are consistent with literature demonstrating
a role for E2 in increasing activation of GSK3β (Cardona-Gomez, 2004; Varea et al, 2009).
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However, GSK3β may interface with additional cell signaling pathways that are involved in E2mediated memory enhancement, such as the PI3K pathway. The idea that GSK3β plays
multifaceted roles in cell-signaling activity, which is well supported by evidence suggesting that
GSK3β is a ubiquitous kinase that interfaces with PI3K, Akt, and mTOR (for review, see
Hermida et al, 2017), merits further research. Apart from its described role in Wnt/β-catenin
signaling, GSK3β is reported to have over 100 identified substrates (Sutherland, 2011), and is
predicted to interact with many more. Consistent with this idea, researchers have posited that
there are multiple available pools of GSK3β that are both physically and functionally distinct,
such that activation of GSK3β does not necessarily result in activation of Wnt/β-catenin
signaling (Beurel et al, 2015; Wu and Pan, 2010). Thus, E2-mediated increases in phosphorylated
GSK3β may occur independently of Wnt/β-catenin signaling activity.
The observed effects of Dkk-1 on levels of Wnt/β-catenin signaling proteins, especially
compared to the robust effects of Dkk-1 on these proteins we previously observed (Fortress et al,
2013), may be due to our use of a lower, behaviorally subeffective dose of Dkk-1, or
examination of time points at which Dkk-1 does not most strongly exert its effects. We chose to
examine changes in protein expression 5 min after infusion based on our previous work showing
that E2 activates numerous other kinases within 5 min (Fernandez et al., 2008; Fortress et al.,
2013), but we were surprised to find limited effects on Wnt/β-catenin signaling. Inclusion of a 45
min time point was guided by data from our lab and others showing the effects of E2 on GSK3β
and β-catenin activity occurring largely within a 1 h window (Cardona-Gomez et al, 2004;
Fortress et al, 2013). Examining more extended time points in future work may aid in
characterizing the interactions among E2, Dkk-1, and Wnt/β-catenin signaling. Despite our
surprisingly modest biochemical effects on Wnt/β-catenin proteins, our behavioral data
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concretely demonstrate that this dose of Dkk-1 can block the memory-enhancing effects of E2.
Importantly, we found no effects of Dkk-1 infusion or E2 infusion on levels of β-catenin (data
not shown), which is a primary downstream effector of Wnt/β-catenin signaling. Thus, we
further hypothesized that Dkk-1 may act through alternative non-canonical Wnt pathways to
block the effects of E2 on memory consolidation.
Despite the general consensus that Dkk-1 antagonizes Wnt/β-catenin signaling, multiple
recent studies have suggested more diverse roles for Dkk-1. Thus, we chose to examine
Wnt/JNK signaling, a pathway originally identified for its role in regulating epithelial cell
polarity in Drosophila and gastrulation in vertebrates (Boutros et al, 1998, Sokol 2000).
Although to the best of our knowledge, no published studies have demonstrated a role for
Wnt/JNK signaling in memory processes, Dkk-1 appears to promote synapse disassembly by
concurrent blockade of Wnt/β-catenin signaling and activation of RhoA-Rock signaling, both
elements of the Wnt/JNK cascade (Marzo et al., 2016). We chose to examine levels of
phosphorylated JNK protein and the synaptic vesicle membrane protein synaptophysin because
both JNK and synaptophysin may play a role in synaptic plasticity, and in turn, affect memory
processes (Mao and Wang, 2016; Tarsa and Goda, 2002).
We found that DH infusion of Dkk-1 increases phosphorylated JNK protein in the DH,
whereas ICV infusion of E2 has no effect on levels of this protein. Furthermore, DH infusion of
Dkk-1 decreased synaptophysin protein levels; this decrease was mitigated by ICV infusion of
E2. Combined, these data suggest that Dkk-1 may exert non-canonical effects in the DH through
Wnt/JNK signaling. Our data are consistent with other research demonstrating a β-cateninindependent, and JNK-dependent, role for Dkk-1. For example, in human mesothelioma cell
lines deficient in β-catenin, Dkk-1 still acts as a tumor suppressor, indicating that Dkk-1 can act

	
  

25	
  

in a β-catenin independent manner (Lee et al, 2004). Evidence from studies using Xenopus and
zebrafish also suggests that Dkk-1 can operate independently of β-catenin to regulate gastrulation
through Wnt/JNK signaling, as evidenced by a robust increase in JNK phosphorylation
(Caneparo et al, 2007). Additionally, in an Alzheimer’s disease mouse model, transcriptional
upregulation of genes that mediate the development of Aβ pathology appears to be primarily
driven by Dkk-1-mediated activation of Wnt/JNK signaling (Killick et al, 2014). Our data
showing a decrease in levels of synaptophysin protein and increase in levels of phosphorylated
JNK mediated by Dkk-1 are supported by the finding that Dkk-1 promotes synapse disassembly
through a JNK-dependent mechanism (Marzo et al, 2016), and the finding that synaptophysin
plays a functional role in regulating activity-dependent synapse formation (Tarsa and Goda,
2002). Moreover, in the present study, we demonstrated modest effects of Dkk-1 on suppressing
Wnt/β-catenin signaling in combination with our finding of Dkk-1 mediated JNK activation,
supporting the hypothesis that Dkk-1 my act bidirectionally to suppress canonical Wnt activity
while enhancing Wnt/JNK activity. These data, in combination with those from the current
study, suggest a novel role for Dkk-1 in altering Wnt/JNK signaling.
We also examined Wnt/Calcium signaling and its downstream effector PKC, given that
in addition to its role in regulating cell adhesion and motility, Wnt/Calcium signaling also
appears to be critical for dendritic arborization and synaptic plasticity (Cerpa et al, 2011; Chen et
al, 2017; Kuhl et al. 2000). We demonstrated in the present study that E2 increases
phosphorylated PKC protein, but that Dkk-1 does not mitigate this increase. E2 may increase
levels of phosphorylated PKC independent of Wnt/Calcium signaling activity; indeed, E2induced increases in phosphorylated PKC are well documented. Given that infusion of Dkk-1
into the DH does not independently alter levels of phosphorylated PKC, the current study
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suggests that Dkk-1 may signal through JNK, but not through the Wnt/Calcium signaling
pathway, to impair memory consolidation. These data lend credence to the idea that Dkk-1 may
act in a bidirectional fashion to block Wnt/β-catenin signaling while also simultaneously
activating Wnt/JNK signaling in the DH, and suggest that Dkk-1 operates independently of the
Wnt/Calcium signaling pathway. Future studies must take into account that Dkk-1 may not
specifically interact with Wnt/β-catenin signaling as previously thought, and more work remains
to pinpoint the precise roles of Dkk-1 in mediating Wnt/JNK signaling.
The current study suggests a novel role for Dkk-1 in preventing the E2-induced
enhancement of memory consolidation via activation of JNK signaling. Recent data from our lab
posit that a specific estrogen receptor, GPER, enhances memory through activation of JNK
signaling, rather than ERK signaling (Kim et al, 2016). Although the current data contradict the
idea that JNK activation enhances memory consolidation, the interactions between Dkk-1 and E2
may depend on its interaction with other estrogen receptors in the hippocampus, such as ERα or
ERβ, rather than GPER. Indeed, the memory-enhancing effects of E2 appear to activate cellsignaling cascades independent of GPER, given that GPER activation within the DH is not
necessary for E2 to enhance memory (Kim et al, 2016). Future work should investigate the
potential estrogen receptor mechanisms mediating the interaction between E2 and Dkk-1.
In conclusion, the present study demonstrates that Dkk-1 infusion into the DH block the
effects of E2 on object recognition and spatial memory consolidation in OVXed mice. Although
much more work remains to identify the precise mechanism through which this interaction
occurs, the present study suggests that Dkk-1 might operate bi-directionally to inhibit Wnt/βcatenin signaling while also promoting Wnt/JNK signaling in the DH. These findings provide
novel insight into the ways in which Dkk-1 acts within the DH, and contribute to a growing body
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of literature indicating that Dkk-1 may function in additional capacities that were not previously
appreciated. Our findings implicate novel pathways involved in the memory-enhancing effects of
E2.
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